Heidelberg Pharma AG (HPHA) - Cash Flow Conversion Efficiency

Latest as of May 2025: -0.299x

Based on the latest financial reports, Heidelberg Pharma AG (HPHA) has a cash flow conversion efficiency ratio of -0.299x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.53 Million ≈ $-6.46 Million USD) by net assets (€18.52 Million ≈ $21.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HPHA equity financing ratio to measure how much of total assets are equity-financed.

Heidelberg Pharma AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Heidelberg Pharma AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HPHA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Heidelberg Pharma AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heidelberg Pharma AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DAE-IL Corporation KO:092200	0.052x
PRECIA SA EO -50 F:P1E0	N/A
Bank Capital Indonesia Tbk JK:BACA	-0.276x
Baozun Inc NASDAQ:BZUN	0.000x
Baiksan KO:035150	0.077x
Horizon Gold Ltd AU:HRN	-0.016x
Mammoth Energy Services Inc NASDAQ:TUSK	-0.010x
RF Acquisition Corp III Ordinary Shares NASDAQ:RFAM	-0.001x

Annual Cash Flow Conversion Efficiency for Heidelberg Pharma AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of Heidelberg Pharma AG from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see HPHA market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-11-30	€30.87 Million ≈ $36.09 Million	€-29.59 Million ≈ $-34.59 Million	-0.959x	-40.46%
2023-11-30	€49.34 Million ≈ $57.68 Million	€-33.67 Million ≈ $-39.37 Million	-0.682x	-413.10%
2022-11-30	€66.64 Million ≈ $77.91 Million	€-8.86 Million ≈ $-10.36 Million	-0.133x	+96.65%
2021-11-30	€6.70 Million ≈ $7.83 Million	€-26.61 Million ≈ $-31.11 Million	-3.973x	-185.96%
2020-11-30	€12.88 Million ≈ $15.06 Million	€-17.89 Million ≈ $-20.92 Million	-1.389x	-164.54%
2019-11-30	€16.29 Million ≈ $19.05 Million	€-8.56 Million ≈ $-10.00 Million	-0.525x	-36.17%
2018-11-30	€25.89 Million ≈ $30.26 Million	€-9.98 Million ≈ $-11.67 Million	-0.386x	-79.83%
2017-11-30	€37.02 Million ≈ $43.28 Million	€-7.94 Million ≈ $-9.28 Million	-0.214x	+67.98%
2016-11-30	€9.76 Million ≈ $11.41 Million	€-6.53 Million ≈ $-7.64 Million	-0.670x	--

About Heidelberg Pharma AG

F:HPHA Germany Biotechnology

Market Cap

$137.83 Million

€117.90 Million EUR

Market Cap Rank

#17954 Global

#1684 in Germany

Share Price

€2.52

Change (1 day)

+2.02%

52-Week Range

€2.31 - €4.46

All Time High

€8.94